SWOT Analysis for Fermenta Biotech Ltd.

Add SWOT widget to your site/app

High DVM Mid and Small Caps (subscription)
Growth Factor Screener: Rising returns on equity (ROE), Momentum, and Earnings Yield
Benjamin Graham Value Screen
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE
Undervalued Growth Stocks
Strong Momentum: Price above short, medium and long term moving averages
Jim Slater's Zulu Principle (Discover Growth Stocks)
High DVM Midcap Stocks (MarketCap 1000-10,000)
Relative Outperformance versus Industry over 1 Year
Affordable Stocks with High ROE and Momentum
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Dividend yield greater than sector dividend yield
High Momentum Scores (Technical Scores greater than 50)
Good quarterly growth in the recent results
Relative Outperformance versus Industry over 1 Week
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Annual Net Profits improving for last 2 years
Companies with Zero Promoter Pledge
Recent Results : Growth in Operating Profit with increase in operating margins (YoY)
RSI indicating price strength
High Volume, High Gain
MACD crossed above zero line previous end of day
Biggest Price Gainers from Open
Top Gainers
High Volume, High Gain
Volume Shockers
Stocks Outperforming their Industry Price Change in the Quarter

High DVM Mid and Small Caps (subscription)

Growth Factor Screener: Rising returns on equity (ROE), Momentum, and Earnings Yield

Benjamin Graham Value Screen

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE

Undervalued Growth Stocks

Strong Momentum: Price above short, medium and long term moving averages

Jim Slater's Zulu Principle (Discover Growth Stocks)

High DVM Midcap Stocks (MarketCap 1000-10,000)

Relative Outperformance versus Industry over 1 Year

Affordable Stocks with High ROE and Momentum

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Dividend yield greater than sector dividend yield

High Momentum Scores (Technical Scores greater than 50)

Good quarterly growth in the recent results

Relative Outperformance versus Industry over 1 Week

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Annual Net Profits improving for last 2 years

Companies with Zero Promoter Pledge

Recent Results : Growth in Operating Profit with increase in operating margins (YoY)

RSI indicating price strength

High Volume, High Gain

MACD crossed above zero line previous end of day

Biggest Price Gainers from Open

Top Gainers

High Volume, High Gain

Volume Shockers

Stocks Outperforming their Industry Price Change in the Quarter

Companies with growing costs YoY for long term projects
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Declining Revenue every quarter for the past 2 quarters
Declining profits every quarter for the past 2 quarters
Declining Net Cash Flow : Companies not able to generate net cash
Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)
Increasing Trend in Non-Core Income

Companies with growing costs YoY for long term projects

Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years

Declining Revenue every quarter for the past 2 quarters

Declining profits every quarter for the past 2 quarters

Declining Net Cash Flow : Companies not able to generate net cash

Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)

Increasing Trend in Non-Core Income

Weekly Momentum Gainers

Weekly Momentum Gainers

Strong Performers - High DVM Stocks
Bullish or Bearish Candlestick Strength - Indices
Bullish Engulfing Pattern (Bullish Reversal)
Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
Declining Net Cash Flow and Cash from Operating Activity for last 2 years
Decline in Net Profit with falling Profit Margin (QoQ)

Strong Performers - High DVM Stocks

Bullish or Bearish Candlestick Strength - Indices

Bullish Engulfing Pattern (Bullish Reversal)

Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Declining Net Cash Flow and Cash from Operating Activity for last 2 years

Decline in Net Profit with falling Profit Margin (QoQ)

Fermenta Biotech Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Fermenta Biotech Ltd. has 33 Strengths, 7 Weaknesses, 1 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential